Clinical Study to Evaluate the Non-inferiority of PRO-122 an Ophthlamic Solution Manufactured by Laboratorios Sophia, Previous Treatment With Krytantek Ofteno ®, in Subjects With Primary Open-Angle Glaucoma or Ocular Hypertension.
Phase of Trial: Phase III
Latest Information Update: 10 Dec 2019
Price : $35 *
At a glance
- Drugs Brimonidine/dorzolamide/timolol (Primary)
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Registrational; Therapeutic Use
- Acronyms CONFORTK
- Sponsors Laboratorios Sophia
- 01 Jun 2018 Primary endpoint of intraocular pressure has been met, according to results published in the Ophthalmology and Therapy.
- 01 Jun 2018 Results published in the Ophthalmology and Therapy
- 28 Aug 2017 New trial record